tiprankstipranks
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
Company AnnouncementsTransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
24d ago
8K
RNAZ
Transcode Therapeutics enters exclusive license agreement with Unleash
PremiumThe Fly
Transcode Therapeutics enters exclusive license agreement with Unleash
24d ago
RNAZ
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
PremiumCompany Announcements
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
1M ago
8K
RNAZ
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
PremiumCompany Announcements
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
2M ago
8K
RNAZ
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
PremiumThe Fly
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
2M ago
RNAZ
TransCode Therapeutics reports promising preclinical glioblastoma results
PremiumCompany AnnouncementsTransCode Therapeutics reports promising preclinical glioblastoma results
3M ago
8K
RNAZ
Transcode Therapeutics announces publication of data supporting TTX-MC138
Premium
The Fly
Transcode Therapeutics announces publication of data supporting TTX-MC138
3M ago
RNAZ
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
Premium
Company Announcements
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
3M ago
8K
RNAZ
TransCode Announces Collaboration for Phase 2a Trial
PremiumCompany Announcements
TransCode Announces Collaboration for Phase 2a Trial
4M ago
8K
RNAZ
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
PremiumThe Fly
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
4M ago
RNAZ
TransCode Therapeutics Amends Preferred Stock Designation
PremiumCompany Announcements
TransCode Therapeutics Amends Preferred Stock Designation
5M ago
8K
RNAZ
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
PremiumCompany Announcements
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
5M ago
8K
RNAZ
Transcode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
PremiumThe FlyTranscode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
5M ago
RNAZ
TransCode Therapeutics Acquires Polynoma and Secures Investment
Premium
Company Announcements
TransCode Therapeutics Acquires Polynoma and Secures Investment
6M ago
8K
RNAZ
Transcode Therapeutics Inc trading resumes
Premium
The Fly
Transcode Therapeutics Inc trading resumes
6M ago
RNAZ
Transcode Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Transcode Therapeutics Inc trading halted, volatility trading pause
6M ago
RNAZ
Transcode Therapeutics to acquire Polynoma
PremiumThe Fly
Transcode Therapeutics to acquire Polynoma
6M ago
RNAZ
TransCode Therapeutics Amends Patent License Agreement
PremiumCompany Announcements
TransCode Therapeutics Amends Patent License Agreement
6M ago
8K
RNAZ
TransCode Therapeutics Passes Key Proposals at Annual Meeting
PremiumCompany Announcements
TransCode Therapeutics Passes Key Proposals at Annual Meeting
7M ago
8K
RNAZ
Transcode Therapeutics Inc trading resumes
PremiumThe FlyTranscode Therapeutics Inc trading resumes
8M ago
RNAZ
Transcode Therapeutics Inc trading halted, volatility trading pause
Premium
The Fly
Transcode Therapeutics Inc trading halted, volatility trading pause
8M ago
RNAZ
TransCode Therapeutics Announces 2025 Annual Meeting Date
Premium
Company Announcements
TransCode Therapeutics Announces 2025 Annual Meeting Date
10M ago
8K
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >